New York’s Office of Cannabis Management (OCM) announced this week that the state’s medical marijuana program is being significantly expanded.
The OCM says that effective immediately physicians will be able to recommend medical marijuana for literally any condition they feel it can be useful for. This is a stark change from the state’s previous policy (and the policy of most other medical marijuana states), which allowed medical marijuana to be recommended for a set list of conditions such as cancer and multiple sclerosis. The change comes as New York prepares for implementation of its recreational marijuana program, which was signed into law by then-Governor Cuomo last year.
“It is terrific to see the Medical Cannabis Program expand so vastly with the launch of the new certification and registration program and the ability of practitioners to determine qualifying conditions as included in the MRTA,” said Tremaine Wright, Chair of the Cannabis Control Board (CCB). “The new cannabis industry is taking shape as we continue to implement the MRTA and provide greater access for New Yorkers to a medicine that we’re learning more about every day.”